ceot symposium: prospera dd-cfdna upheld as a leading indicator for kidney transplant rejection
Published 5 months ago • 317 plays • Length 59:21Download video MP4
Download video MP3
Similar videos
-
54:26
molecular-level insights in kidney and pancreas transplant care: prospera deep dive
-
1:02:35
"evolving biomarkers in kidney transplantation," presented by ast and isot
-
5:51
subcutaneous implantable cardioverter defibrillators in dialysis patients
-
1:17
transplant surgeon explains how machine rejuvenates less-than-ideal donor kidneys
-
4:25
the prognostic value of quantitative analysis of ccl5 and collagen iv – video abstract [id 159585]
-
0:57
scott kopetz, md, phd, facp, on the potential of binimetinib immunotherapy in mcrc patients
-
1:46
new resource for kidney transplant patients
-
0:29
mr gabriel oniscu - transplant surgeon
-
2:58
evripidis gavathiotis, phd - 2015 pershing square sohn prize winner
-
1:17
milliporesigma: new cellvento® - designed to support growth & maintenance of specific cho cell lines
-
2:48
interview with insightec president and ceo, kobi vortman
-
1:55
when is a patient transplant eligible?
-
2:10
what is the ceo disease?
-
1:31
prognostic value of the dcis score in breast cancer
-
1:00:18
cancer disparities in the 21st century
-
3:24
éminence organic skin care made in hungary
-
1:50
community testimonial: cadmus rich